014950 — Samik Pharm Co Balance Sheet
0.000.00%
Last trade - 00:00- KR₩142bn
- KR₩124bn
- KR₩56bn
Annual balance sheet for Samik Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 8,766 | 12,608 |
| Net Total Accounts Receivable | ||
| Net Total Receivables | 9,628 | 9,109 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 28,658 | 34,129 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 25,389 | 24,963 |
| Net Intangible Assets | ||
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 59,032 | 64,309 |
| Accounts Payable | ||
| Payable / Accrued | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 8,876 | 10,432 |
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Deferred Income Tax | ||
| Total Other Liabilities | ||
| Total Funded Status | ||
| Total Liabilities | 10,697 | 12,357 |
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| ESOP Debt Guarantee | ||
| Other Equity | ||
| Total Equity | 48,335 | 51,952 |
| Total Liabilities & Shareholders' Equity | 59,032 | 64,309 |
| Total Common Shares Outstanding |